78 FR 62 pg. 19489 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
Type: NOTICEVolume: 78Number: 62Page: 19489
FR document: [FR Doc. 2013-07442 Filed 3-29-13; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Low Dose CT Lung Cancer Screening: Informed Decision Making and Smoking Cessation, Special Interest Project (SIP)13-068; and Tobacco Use Quitline Registries for Continuously Engaging Participants in Cessation, SIP13-073, Panel C, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11:00 a.m.-6:00 p.m., May 9, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of "Low Dose CT Lung Cancer Screening: Informed Decision Making and Smoking Cessation, SIP13-068; and Tobacco Use Quitline Registries for Continuously Engaging Participants in Cessation, SIP13-073, Panel C, initial review."
Contact Person For More Information:
M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-46, Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013-07442 Filed 3-29-13; 8:45 am]
BILLING CODE 4163-18-P